Enabling early diagnosis and efficient management of neurodegenerative diseases

Problem

Healthcare professionals are often overwhelmed with data, making the interpretation challenging in clinical decision making.

 

Solution

cNeuro® from Combinostics gives healthcare professionals a comprehensive view of patient data which helps them to make an early diagnosis of neurodegenerative diseases. 

While there are no effective treatments for neurodegenerative diseases like Alzheimer’s, early-stage diagnosis combined with symptomatic treatment and lifestyle intervention can make a drastic difference to quality of life in later years.

Products

cNeuro® is Combinostics’ cloud platform for quantitative assessment of brain images and for providing clinical decision support in neurological disorders.

cNeuro® has two product modules, cMRI and cDSI.

cNeuro® cMRI

Quantify volumes of 133 brain regions, vascular burden and in the EU, compute medial temporal lobe atrophy (MTA) score, global cortical atrophy (GCA) scale and Fazekas scale.

Compare measures to reference data.

Review results interactively in a web viewer using a standard web browser and obtain a report.

cNeuro® cDSI

Compare neuropsychology, MRI, CSF and genetics measured from your patient to data of previously diagnosed cases.

Quantify the patient’s similarity relative to etiology (AD, FTLD, VaD and cognitive normal) and progression (stable and progressive MCI).

Visualize data in an intuitive way with our patented disease state fingerprint (DSI) technology.

Meet us at RSNA

Combinostics will be attending the RSNA conference in Chicago December 1 – 6. You can find us in the AI Showcase, Level 1, North Hall, booth 10532B (see floorplan).

read more

Want to know more